C-Abl is an effector of Src for growth factor-induced c-myc expression and DNA synthesis

EMBO Journal

Volumn 21, Issue 4, 2002, Pages 514-524

  Furstoss, Olivia ^a   Dorey, Karel ^b   Simon, Valérie ^a   Barilà, Daniela ^b,c   Superti Furga, Giulio ^b   Roche, Serge ^a  

^a Centre National de la Recherche Scientifique   (France)

^b EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^c University of Via di Tor Vergata 135   (Italy)

Author keywords

c Abl; c Myc; c Src; DNA synthesis; Growth factors

Indexed keywords

ABELSON KINASE; GROWTH FACTOR; MYC PROTEIN; NEUTRALIZING ANTIBODY; ONCOPROTEIN; PLATELET DERIVED GROWTH FACTOR; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CYCLE G1 PHASE; CONTROLLED STUDY; CYTOPLASM; DNA SYNTHESIS; ENZYME INACTIVATION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; GROWTH REGULATION; MICROINJECTION; MITOGENESIS; MITOSIS INHIBITION; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; CELLS, CULTURED; CYTOPLASM; DNA REPLICATION; GENES, MYC; MICE; MITOSIS; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PLATELET-DERIVED GROWTH FACTOR; PROTO-ONCOGENE PROTEINS C-ABL; PROTO-ONCOGENE PROTEINS PP60(C-SRC); SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0037084333     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/21.4.514     Document Type: Article

References (43)

1. Src family tyrosine kinases and growth factor signaling
2. Differential complementation of Bcr-Abl point mutants with c-Myc
3. An intramolecular SH3-domain interaction regulates c-Abl activity
4. A nuclear tyrosine phosphorylation circuit: C-Jun as an activator and substrate of c-Abl and JNK
5. Myc but not Fos rescue of PDGF signalling block caused by kinase-inactive Src
6. SU6656, a selective Src family kinase inhibitor, used to probe growth factor signaling
7. Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis
8. c-Abl has high intrinsic tyrosine kinase activity that is stimulated by mutation of the Src homology 3 domain and by autophosphorylation at two distinct regulatory tyrosines
9. No requirement for Src family kinases for PDGF signaling in fibroblasts expressing SV40 large T antigen
10. Requirement for c-Src catalytic activity and the SH3 domain in platelet-derived growth factor BB and epidermal growth factor mitogenic signaling
11. Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors
12. Regulation of c-myc expression by PDGF through Rho GTPases
13. Cytoskeletal protein PSTPIP1 directs the PEST-type protein tyrosine phosphatase to the c-Abl kinase to mediate Abl dephosphorylation
14. Phosphorylation and structure-based functional studies reveal a positive and a negative role for the activation loop of the c-Abl tyrosine kinase
15. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells
16. STAM2, a new member of the STAM family, binding to the Janus kinases
17. Tyrosine phosphorylation sites at amino acids 239 and 240 of Shc are involved in epidermal growth factor-induced mitogenic signaling that is distinct from Ras/mitogen-activated protein kinase activation
18. Essential roles for the Abl and Arg tyrosine kinases in neurulation
19. Anti-apoptotic activity of p53 maps to the COOH-terminal domain and is retained in a highly oncogenic natural mutant
20. Integrin regulation of c-Abl tyrosine kinase activity and cytoplasmic-nuclear transport
21. Slap inhibits the Src-mitogenic function but does not affect Src-induced cell transformation
22. Identification of a novel immunoreceptor tyrosine-based activation motif (ITAM)-containing molecule, STAM2, in growth factor and cytokine receptor signaling pathways by mass spectrometry
23. c-Abl is activated by growth factors and Src family kinases and has a role in the cellular response to PDGF
24. Growth regulation of a cellular turnout antigen, p53, in nontransformed cells
25. DNA synthesis induced by some but not all growth factors requires Src family protein tyrosine kinases
26. Requirement of phospholipase C γ, the tyrosine phosphatase Syp and the adaptor proteins Shc and Nck for PDGF-induced DNA synthesis: Evidence for the existence of Rasdependent and Ras-independent pathways
27. Chronic myeloid leukemia
28. Dominant negative MYC blocks transformation by ABL oncogenes
29. The nuclear tyrosine kinase c-Abl negatively regulates cell growth
30. Ras enhances Myc protein stability
31. STAM, signal transducing adaptor molecule, is associated with Janus kinases and involved in signaling for cell growth and c-myc induction
32. Ternary complex factors: Growth factor regulated transcriptional activators
33. The Src family tyrosine kinases are required for plateletderived growth factor-mediated signal transduction in NIH 3T3 cells
34. Receptor proteintyrosine kinases and their signal transduction pathways
35. Cycling, stressed-out and nervous: Cellular functions of c-Abl
36. Induction of apoptosis in chronic myelogenous leukemia cells through nuclear entrapment of BCR-ABL tyrosine kinase
37. S26 ribosomal protein RNA: An invariant control for gene regulation experiments in eucaryotic cells and tissues
38. SREBP-1, a membrane-bound transcription factor released by sterolregulated proteolysis
39. The cytostatic function of c-Abl is controlled by multiple nuclear localization signals and requires the p53 and Rb tumor suppressor gene products
40. v-Abl activates c-myc transcription through the E2F site
41. Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein
42. Role for c-Abl tyrosine kinase in growth arrest response to DNA damage
43. Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging